• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Turkey Pharmaceuticals and Healthcare Report Q2 2008 Product Image

Turkey Pharmaceuticals and Healthcare Report Q2 2008

  • Published: May 2008
  • 73 pages
  • Business Monitor International

FEATURED COMPANIES

  • Abdi Ibrahim
  • AstraZeneca
  • Biomeks
  • Merck & Co
  • Pfizer
  • Sanofi-Aventis
  • MORE

The Turkey Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Turkeys pharmaceuticals and healthcare industry.

The Turkish pharmaceutical market is set to increase in value from an estimated US$7.9bn to US$12.5bn in 2012. The introduction of the new universal health insurance system, a landmark in the development of the Turkish health sector, will be a considerable factor in helping the industry modernise. In the meantime, local production will continue to be focused on generics, with unregistered copies remaining commonplace. The domestic industry’s research and development (R&D) capacity has historically been severely limited due to a lack of investment. However, this is likely to change, with foreign interest in the form of increased acquisition activity already in evidence.

For Q208, BMI’s Business Environment Rating once again places Turkey in second place, below only the United Arab Emirates (UAE). While its commercial potential is boosted by a large and expanding population, stringent price controls, an unstable political environment and deficiencies in its intellectual property (IP) regime represent READ MORE >

Executive Summary
Turkey Pharmaceuticals And Healthcare Industry SWOT
Turkey Political SWOT
Turkey Economic SWOT
Turkey Business Environment SWOT
Pharmaceutical Business Environment Rating
Table: Business Environment Rankings For The Middle East And Africa
Limits Of Potential Returns
Risks To Realisation Of Returns 0
Turkey - Market Summary
Regulatory Regime
Intellectual Property Regime
Intellectual Property Shortcomings
Pricing Regime
Table: Turkish Pharmacy And Wholesale Mark-Ups
Reimbursement Regime
Industry Developments
Health Profile
Healthcare Sector
Healthcare Expenditure
Healthcare Sector Reforms
Health Insurance
Pharmaceutical Sector
Pharmaceutical Retail and Distribution
Recent Pharmaceutical Sector Developments
International Co-operation
Research And Development Sector
Medical Devices
Industry Forecast Scene
Overall Market Forecast
Table: Drug Expenditure And Prescription Market Indicators (US$mn unless otherwise stated)
Key Growth Factors - Industry
Table: Healthcare Expenditure Trends
Key Growth Factors - Macroeconomic
Table: Turkey - Economic Activity
Patented Drug Market Forecast
Table: Patented Market Trends (US$mn unless otherwise stated)
Generics Market Forecast
Table: Generics Market Trends
OTC Market Forecast
Table: OTC Market Trends (US$bn unless otherwise stated)
Export/Import Market Forecasts
Table: Pharmaceutical Trade Indicators (US$mn)
Other Healthcare Data
Table: General Healthcare Indicators
Key Risks To our Forecast Scenario
Competitive Landscape
Table: Top 10 Pharmaceutical Companies In Turkey By Market Share, 2006

Company Profiles
- Novartis
- Sanofi-Aventis
- GlaxoSmithKline
- Pfizer
- Roche
- AstraZeneca
- Bayer
- Merck & Co
- Abdi Ibrahim
- Eczacibasi Pharmaceuticals
- Sanovel Pharmaceuticals
- EastPharma (formerly Deva Holding)
- Actavis (formerly Fako)
- Biomeks

Our Forecast Modelling
How We Generate Our Industry Forecasts
Pharmaceutical Industry
Pharmaceutical Business Environment Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Sources



- Novartis
- Sanofi-Aventis
- GlaxoSmithKline
- Pfizer
- Roche
- AstraZeneca
- Bayer
- Merck & Co
- Abdi Ibrahim
- Eczacibasi Pharmaceuticals
- Sanovel Pharmaceuticals
- EastPharma (formerly Deva Holding)
- Actavis (formerly Fako)
- Biomeks

Format Properties
Electronic (PDF) The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.
Note: Product cover images may vary from those shown
More

RELATED PRODUCTS

Our Clients

Our clients' logos